Please find enclosed the Annual Report 2012 for approval at the Annual General Meeting 15 May 2013.
These documents are also available on www.bionorpharma.com.
Bionor Pharma ASA
Hilde Aalling Syvertsen,
-Director Communications & Corporate Affairs
-Director Communications & Corporate Affairs
Tel +47 23 01 09 60
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.